Skip to content

Addiction: all studies

Page 421 of 859: studies 4,201 to 4,210 of 8,590, newest first. Back to the addiction overview

Research

Path of intuitive compassion to transform conflicts into enduring peace and prosperity: Symmetry across domains of reiterated prisoner's dilemma, dyadic active inference, and Mahayana Buddhism

Frontiers in Psychology March 9, 2023 Shao-Hsuan Shaun Ho, Yoshio Nakamura, James E. Swain 3 citations

Conflicts are increasingly intensified among the members of the community, making it almost impossible to extend compassion—defined as a wish to relieve others from suffering—from one side to the other, especially when both sides believe that “life is a battle of us the good vs. them the evil.” Is compassion even relevant to conflicts? The answer depends on how a conflict is framed in one's...

Mindfulness Abilities Are Associated with Anxiety Levels, Emotional Intelligence, and Perceived Self-Efficacy

Sustainability March 7, 2023 Inés Martínez-Pérez, Almudena García-Rodríguez, Francisco Manuel Morales Rodríguez et al. 16 citations

This study examined the relationship between anxiety, emotional intelligence, perceived self-efficacy, and mindfulness abilities. A total of 205 Spanish university students were assessed for mindfulness (Freiburg Mindfulness Inventory-14), state-trait anxiety (State-Trait Anxiety Inventory), emotional intelligence (Trait Meta-Mood Scale-24), and general perceived self-efficacy (General...

Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?

Clinical Chemistry March 7, 2023 Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett et al.

The clinical evaluation of hallucinogens and other small molecules, conventionally termed psychedelics, has seen a dramatic increase in the past 5 years. Several key clinical trials recently demonstrated the potential efficacy of these compounds in treating a variety of mental health conditions including depression, anxiety, and substance use disorders. Concurrently, the business and patent...

DOI: 10.1093/clinchem/hvad016 (opens in new tab) Full text (opens in new tab) Officer Chapel Vice president Library science +4

Successful treatment of dextromethorphan use disorder with combined naltrexone and gabapentin: a case report

The American Journal of Drug and Alcohol Abuse March 4, 2023 Nicole Ledwos, Aurelia I Andreiev, Tianna Costa et al.

NyQuil is an over-the-counter medication containing the pain reliever, acetaminophen; the antihistamine, doxylamine; and dextromethorphan (DXM), the antitussive medication. The Nyquil liquid formulation also contains alcohol, listed among the inactive ingredients. DXM has dependence-producing properties and addiction liability, especially in young people (1). Large doses (>1500 mg/day) can...

Altered parasympathetic activity during sleep and emotionally arousing wakefulness in frequent nightmare recallers

European Archives of Psychiatry and Clinical Neuroscience March 2, 2023 Vivien Tomacsek, Borbála Blaskovich, Anna Király et al. 8 citations

Nightmare disorder is characterized by dysfunctional emotion regulation and poor subjective sleep quality reflected in pathophysiological features such as abnormal arousal processes and sympathetic influences. Dysfunctional parasympathetic regulation, especially before and during rapid eye movement (REM) phases, is assumed to alter heart rate (HR) and its variability (HRV) of frequent nightmare...

Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training?

Cambridge Quarterly of Healthcare Ethics March 2, 2023 Nathan Emmerich, Bryce Humphries 27 citations

Recent research offers good reason to think that various psychedelic drugs-including psilocybin, ayahuasca, ketamine, MDMA, and LSD-may have significant therapeutic potential in the treatment of various mental health conditions, including post-traumatic stress disorder, depression, existential distress, and addiction. Although the use of psychoactive drugs, such as Diazepam or Ritalin, is well...

Mentation processes such as excessive mind wandering, rumination, and mindfulness mediate the relationship between ADHD symptoms and anxiety and depression in adults with ADHD

European Psychiatry March 1, 2023 Ali Kandeğer, Şerife Odabaş Ünal, M. T. Ergün

Introduction: Excessive mind wandering is a common feature of ADHD in adulthood also referred to as mental restlessness and ceaseless mental overactivity. ADHD is a predisposing factor for many psychiatric symptoms, especially negative emotions such as depression and anxiety. Rumination is thought to be a mediator for depression in individuals with ADHD. The above-mentioned mental processes may...

Looking inside the black box of mindfulness meditation: Investigating attention and awareness during meditation using the mindful awareness task (MAT).

Psychological Assessment March 2023 Yuval Hadash, Liad Ruimi, Amit Bernstein

Training attention and awareness in mindfulness meditation is theorized to be essential for the cultivation of mindfulness and its salutary outcomes. Yet, the empirical foundation for this central premise in mindfulness science is surprisingly small due to a limited methodological capacity to measure attention and awareness during mindfulness meditation. Accordingly, we set out to measure and...

Cannabis use during first episode psychosis in Tunisia

European Psychiatry March 1, 2023 E. Bergaoui, R. Lansari, O. Chehaider et al.

IntroductionCannabis use is frequent among patients with psychotic disorders. However, the relationship between cannabis consumption and transition to psychosis has not been fully elucidated.ObjectivesThe aim of this study was to assess the prevalence of cannabis use in first episode psychosis and its correlation with transistion to psychosis and severity of symptoms.MethodsA cross-sectional...

Psychoactive supplements: What to tell patients

Current Psychiatry March 1, 2023 Marija S. Marković 1 citation

Savvy Psychopharmacology M r.D, age 41, presents to the emergency department (ED) with altered mental status and suspected intoxication.His medical history includes alcohol use disorder and spinal injury.Upon initial examination, he is confused, disorganized, and agitated.He receives IM lorazepam 4 mg to manage his agitation.His laboratory workup includes a negative screening for blood alcohol,...